Biocon Limited (NSE:BIOCON)

India flag India · Delayed Price · Currency is INR
363.30
+2.85 (0.79%)
Oct 28, 2025, 11:30 AM IST
0.79%
Market Cap480.99B
Revenue (ttm)157.71B
Net Income (ttm)3.85B
Shares Out1.33B
EPS (ttm)3.21
PE Ratio112.35
Forward PE54.92
Dividend0.50 (0.14%)
Ex-Dividend DateJul 4, 2025
Volume394,518
Average Volume1,855,487
Open360.55
Previous Close360.45
Day's Range359.85 - 363.45
52-Week Range291.00 - 406.00
Beta0.25
RSI54.41
Earnings DateNov 11, 2025

About Biocon

Biocon Limited, together with its subsidiaries, manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics, Biosimilars, and Research segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, multiple sclerosis, anti-fungal, anti-cancer, immunosuppressants, and specialty molecules; and biosimilars products consisting of pegfilgrastim, trastuzumab, bevacizumab, a... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1978
Employees 16,315
Stock Exchange National Stock Exchange of India
Ticker Symbol BIOCON
Full Company Profile

Financial Performance

In 2024, Biocon's revenue was 152.62 billion, an increase of 3.43% compared to the previous year's 147.56 billion. Earnings were 10.13 billion, a decrease of -0.90%.

Financial Statements

News

‘Fabricated news’, says Biocon chief Kiran Mazumdar-Shaw on repairing Bengaluru roads

Biocon chief Kiran Mazumdar-Shaw has dismissed reports claiming she offered to fund Bengaluru road repairs as 'fabricated news.' She expressed amusement and challenged media outlets to reveal their so...

5 days ago - The Times of India

Top stocks to watch today, October 23: DRL, BEL, Biocon, TVS Motor, Tata Motors, and more

Indian stock markets are set for a day of stock-specific movement on October 23, as several listed companies have shared...

5 days ago - Business Upturn

Biocon Biologics gets Health Canada approval for Yesintek

Biocon Biologics Ltd (BBL), a global biosimilars company and a subsidiary of Biocon Ltd (BSE: 532523, NSE: BIOCON), has announced...

5 days ago - Business Upturn

P Chidambaram Says Problem With Fixing Roads Is Not Funds, But Execution

Congress MP P Chidambaram has claimed that Biocon chairperson Kiran Mazumdar-Shaw has offered to fund the repair work of roads in Bengaluru. He welcomed the offer but said that lack of funds isn't the...

5 days ago - NDTV

Kiran Mazumdar-Shaw Shuts Up Troll With "Proud Kannadiga" Post

Biocon founder Kiran Mazumdar-Shaw has hit back at trolls claiming she is not a Kannadiga. The entrepreneur, a prominent voice of India Inc, has been in the crosshairs of trolls after she flagged infr...

5 days ago - NDTV

Kiran Mazumdar-Shaw's "Proud Kannadiga" Post To Hit Back At Trolls

Biocon founder Kiran Mazumdar-Shaw has hit back at trolls claiming she is not a Kannadiga. The entrepreneur, a prominent voice of India Inc, has been in the crosshairs of trolls after she flagged infr...

5 days ago - NDTV

Fix Bengaluru roads: Kiran Mazumdar-Shaw offers funds, Congress MP Chidambaram says problem is execution, not money

Biocon chairperson Kiran Mazumdar-Shaw has offered to fund repairs for Bengaluru's damaged roads, prompting a proposal from P Chidambaram for industry to supervise public works. This initiative aims t...

5 days ago - The Times of India

Kiran Mazumdar-Shaw Offers To Fund Bengaluru Road Repair, P Chidambaram Responds

Congress MP P Chidambaram has welcomed Biocon chairperson Kiran Mazumdar Shaw's offer to fund the repair work of roads in Bengaluru.

5 days ago - NDTV

Kiran Shaw Offers To Fund Bengaluru Road Repair, P Chidambaram Responds

Congress MP P Chidambaram has welcomed Biocon chairperson Kiran Mazumdar Shaw's offer to fund the repair work of roads in Bengaluru.

5 days ago - NDTV

Bengaluru infrastructure row: Days after sparring, Biocon chief Kiran Mazumdar-Shaw meets CM Siddaramaiah, DKS; pledges cooperation & support

BENGALURU: Biocon chief Kiran Mazumdar-Shaw Tuesday met Karnataka CM Siddaramaiah and his deputy D K Shivakumar to greet them on the occasion of Deepa.

6 days ago - The Times of India

Bengaluru infrastructure row: Kiran Mazumdar-Shaw meets deputy CM D K Shivakumar; discusses growth, innovation

Biocon chief Kiran Mazumdar-Shaw met Deputy Chief Minister D K Shivakumar following sharp criticism over Bengaluru's crumbling infrastructure. The discussion focused on the city's growth and innovatio...

6 days ago - The Times of India

Biocon Founder Visits DK Shivakumar Amid Face-Off Over Bengaluru Infra

Kiran Mazumdar-Shaw, Biocon founder and a key voice of India Inc., met Karnataka's Deputy Chief Minister DK Shivakumar at his residence in Bengaluru this morning.

7 days ago - NDTV

"Thin-Skinned Politician": Harsh Goenka As DK Shivakumar Slams Kiran Mazumdar-Shaw

RPG Enterprises' Harsh Goenka hit out at Karnataka Deputy Chief Minister DK Shivakumar after he slammed Biocon chief Kiran Mazumdar-Shaw for criticising Bengaluru's "crumbling infrastructure".

7 days ago - NDTV

"Thin-Skinned Politician": Harsh Goenka As DK Shivakumar Slams Biocon Chief

RPG Enterprises' Harsh Goenka hit out at Karnataka Deputy Chief Minister DK Shivakumar after he slammed Biocon chief Kiran Mazumdar-Shaw for criticising Bengaluru's "crumbling infrastructure".

7 days ago - NDTV

DK Shivakumar hits back at corporate honchos over Bengaluru infrastructure

India News: BENGALURU: The feud between Karnataka deputy CM DK Shivakumar and two of Bengaluru’s most prominent corporate captains — Biocon chairperson Kiran Mazu.

8 days ago - The Times of India

'We lack pride': Kiran Mazumdar-Shaw blasts Bengaluru garbage problem; Biocon chief stands firm after DK Shivakumar's rebuttle

Biocon chief Kiran Mazumdar-Shaw criticized Bengaluru's persistent garbage problem, calling it a "serious malaise" and blaming past governments' inaction. Her remarks drew criticism from Deputy Chief ...

12 days ago - The Times of India

Biocon chief highlights Bengaluru ‘creaking’ infra

BENGALURU: A day after Biocon chief Kiran Mazumdar-Shaw highlighted Bengaluru’s “creaking” infrastructure, Karnataka’s deputy CM D K Shivakumar Wednes.

12 days ago - The Times of India

Kiran Mazumdar-Shaw finds support from BJP MP; Lad continues tirade

Bengaluru: Even as brickbats kept streaming in from ministers for a second straight day, Biocon chief Kiran Mazumdar-Shaw Wednesday found an ally in B.

12 days ago - The Times of India

'Why are roads so bad': Senior Karnataka ministers go after Kiran Mazumdar-Shaw as she flags Bengaluru civic woes; citizens echo Biocon chief's comment

Kiran Mazumdar-Shaw, the visionary behind Biocon, took to social media to express her dismay over Bengaluru's deteriorating infrastructure after a visitor was taken aback by the city's pothole-ridden ...

13 days ago - The Times of India

'Why are roads so bad?': Kiran Mazumdar-Shaw slams Bengaluru infra again; ministers fume

Biocon Chairperson Kiran Mazumdar-Shaw highlighted Bengaluru's poor roads and garbage issues after an overseas visitor's critique. Karnataka ministers responded, stating development work is underway. ...

13 days ago - The Times of India

"Why Are Bengaluru Roads So Bad?" Kiran Mazumdar-Shaw Quotes Chinese Visitor

Biocon Chairperson Kiran Mazumdar-Shaw has once again drawn attention to Bengaluru's poor infrastructure, this time quoting a visitor from China who questioned the state of the city's roads and cleanl...

13 days ago - NDTV

Biocon subsidiary, in partnership with Carnegie Pharmaceuticals, gets USFDA tentative nod for Rifaximin Tablets 550 mg

Biocon Pharma Limited, a wholly owned subsidiary of Biocon Ltd, has received tentative approval from the U.S. Food and Drug...

21 days ago - Business Upturn

Equillium (EQ) Ends Collaboration with Biocon on Itolizumab

Equillium (EQ) Ends Collaboration with Biocon on Itolizumab

21 days ago - GuruFocus

Biocon Biologics secures U.S. launch for Bosaya and Aukelso following settlement with Amgen

Biocon Biologics Ltd. (BBL), a global leader in biosimilars and a subsidiary of Biocon Ltd. (BSE: 532523, NSE: BIOCON), has announced a key settlement and license agreement with Amgen Inc., paving the...

27 days ago - Business Upturn

Not a med emergency: Generic pharma cos spared from harm

Trump's new 100% pharma levy primarily targets branded and patented medicines, potentially impacting Sun Pharma and Biocon's US sales. While most Indian generic firms anticipate business as usual, som...

4 weeks ago - The Times of India